drugset / Trial / NCT07414992
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The researchers are doing this study to find out whether stereotactic body radiation therapy (SBRT) in combination with immunotherapy (cemiplimab with or without fianlimab) before cystectomy is an effective and safe treatment for people with muscle-invasive bladder cancer (MIBC).
Timeline
- Start
- 2026-09
- Primary completion
- 2028-03
- Completion
- 2028-03
Outcome
Outcome not reported
Stopped: “The sponsor is no longer supporting the trial because they are no longer interested in studying the drug in the target patient population.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cemiplimab | Monoclonal antibody | — | — |
| Subject | Fianlimab | Monoclonal antibody | — | — |